AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Allergy Therapeutics plc

5p -$6.90 (-57.98%)
LSE · 16 Sep 2026 07:00 UTC
Previous Close
4.75p
Day Range
5p - 5p
Year Range
4.5p12.1p
Market Cap
316.63M
AVG Volume
448.7K
Trailing/Forward PE
-5.05/543.12
PEG ratio
0.02
Dividend Yield
-
Next Earnings Date
2026-09-24
Primary Exchange
London Stock ExchangeUK
Revenue (GBP)
020M40M60M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Revenue (GBP) by quarter
PeriodRevenue (GBP)
26 Q236.28M
25 Q421.01M
25 Q234.03M
24 Q421.63M
24 Q233.57M
23 Q419.69M
23 Q239.9M
22 Q424.07M
22 Q248.7M
21 Q430.3M
Net Income (GBP)
-40M-20M020M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Net Income (GBP) by quarter
PeriodNet Income (GBP)
26 Q2-19.92M
25 Q4-29.05M
25 Q2-11.09M
24 Q4-24.57M
24 Q2-15.65M
23 Q4-34.56M
23 Q2-8.51M
22 Q4-20.45M
22 Q26.67M
21 Q4-12.05M
Operating Income (GBP)
-30M-20M-10M010M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Operating Income (GBP) by quarter
PeriodOperating Income (GBP)
26 Q2-11.92M
25 Q4-22.59M
25 Q2-6.82M
24 Q4-23.32M
24 Q2-11.89M
23 Q4-27.95M
23 Q2-7.82M
22 Q4-20.15M
22 Q27.17M
21 Q4-8.84M
EBITDA (GBP)
-30M-20M-10M010M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L EBITDA (GBP) by quarter
PeriodEBITDA (GBP)
26 Q2-9.76M
25 Q4-22.96M
25 Q2-6.46M
24 Q4-21.04M
24 Q2-9.7M
23 Q4-29.4M
23 Q2-5.7M
22 Q4-17.69M
22 Q29.82M
21 Q4-9.57M
Cash Flows (GBP)
-30M-20M-10M010M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Cash Flows (GBP) by quarter
PeriodCash Flows (GBP)
26 Q2-14.52M
25 Q4-22.83M
25 Q2-9.15M
24 Q4-23.39M
24 Q2-12.64M
23 Q4-25.13M
23 Q2-10.46M
22 Q4-19.55M
22 Q22.56M
21 Q4-6.17M
EPS (GBP)
-0.06-0.04-0.0200.0221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L EPS (GBP) by quarter
PeriodEPS (GBP)
26 Q2-0
25 Q4-0.01
25 Q2-0
24 Q4-0.01
24 Q2-0.01
23 Q4-0.05
23 Q2-0.01
22 Q4-0.03
22 Q20.01
21 Q4-0.02
Expenses (GBP)
010M20M30M40MR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Expenses (GBP) by quarter
PeriodExpenses (GBP)
26 Q234.05M
25 Q430.53M
25 Q229.2M
24 Q434.07M
24 Q234.61M
23 Q437.19M
23 Q236.48M
22 Q435.66M
22 Q229.89M
21 Q430.68M
Cash & Debt (GBP)
020M40M60MCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Cash & Debt (GBP) by quarter
PeriodCash & Debt (GBP)
26 Q210.08M
25 Q412.79M
25 Q221.68M
24 Q412.91M
24 Q213.52M
23 Q414.85M
23 Q215.2M
22 Q420.52M
22 Q241.38M
21 Q440.27M
Debt ratios
-30-20-1001021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Debt ratios by quarter
PeriodDebt ratios
26 Q2-0.28
25 Q4-0.79
25 Q2-0.36
24 Q4-0.27
24 Q20.06
23 Q4-0.49
23 Q20.23
22 Q4-27.06
22 Q2-2.52
21 Q4-1.67
Margins
0%20%40%60%80%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Margins by quarter
PeriodMargins
26 Q253.26%
25 Q420.31%
25 Q261.3%
24 Q442.62%
24 Q261.12%
23 Q437.91%
23 Q264.62%
22 Q456.48%
22 Q273.74%
21 Q465.95%
Return on Capital
-2000%-1500%-1000%-500%0%500%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Return on Capital by quarter
PeriodReturn on Capital
26 Q2-468.77%
25 Q4103.03%
25 Q2155.03%
24 Q4-662.31%
24 Q2-59.15%
23 Q4-1673.04%
23 Q2-22.41%
22 Q4-53.25%
22 Q212.13%
21 Q4-24.83%
Shares Outstanding
02B4B6B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Shares Outstanding by quarter
PeriodShares Outstanding
26 Q25.22B
25 Q44.77B
25 Q24.77B
24 Q43.76B
24 Q22.7B
23 Q4679.04M
23 Q2659.38M
22 Q4644.2M
22 Q2687.73M
21 Q4641.12M
Book Value Per Share (GBP)
-0.0300.030.050.080.121 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Book Value Per Share (GBP) by quarter
PeriodBook Value Per Share (GBP)
26 Q20
25 Q4-0.01
25 Q2-0
24 Q40
24 Q20.01
23 Q40
23 Q20.06
22 Q40.06
22 Q20.08
21 Q40.08
Total Assets (GBP)
025M50M75M100M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
AGY.L Total Assets (GBP) by quarter
PeriodTotal Assets (GBP)
26 Q271M
25 Q467.54M
25 Q272.97M
24 Q464.83M
24 Q269.08M
23 Q466.77M
23 Q271.61M
22 Q473.58M
22 Q291.97M
21 Q488.09M
Allergy Therapeutics plc
AGY.L
Stockpicker

Video analysis: AGY.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.